menu
    • menu

    Company profile for Glenmark Pharmaceuticals

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South...
    Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India. With 15 manufacturing facilities and 3 R&D centers dedicated to the goal of enriching lives across the globe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Glenmark Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andhe...
    Telephone
    Telephone
    +91 22 4018 9999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.glenmarkpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    This week, SpeakPharma interviews Miquel Bachs, CEO of Inke, a company with over two decades of expertise in micronization and particle engineering, and a leader in providing high-quality, effective solutions in the global fight against chronic respiratory diseases such as COPD and asthma. In this insightful conversation, Bachs shares Inke’s strategic vision, technological innovations, and commitment to sustainability, offering a comprehensive look at how the company is shaping the future of respiratory health. HIGHLIGHTS// Inke’s strategic vision/ technological innovations/ commitment to sustainability Studies suggest that 13 percent of people over 40 years of age, the world over, have chronic obstructive pulmonary disease (COPD). Given the increasing prevalence of respiratory diseases, how does Inke position itself as a leader in the development and manufacturing of respiratory APIs? Inke has established itself as a global leader in generic respiratory API development through our unique blend  of technological innovation, expertise in micronization, and a comprehensive portfolio of inhalation therapies. With over 20 years of experience in micronization and particle engineering, our ability to customize APIs to meet specific client requirements has resulted in highly effective, high-quality products tailored for respiratory therapies. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has only underscored Inke’s pivotal role in supporting the pharmaceutical industry’s need for advanced treatments. We specialize in bronchodilators and other critical respiratory APIs that improve patient outcomes and meet the stringent regulatory requirements of global health authorities. Our end-to-end approach, from early-stage API development to commercial-scale production, ensures that we maintain the highest standards of quality, safety, and efficacy. As the market for respiratory APIs continues to evolve, Inke remains committed to expanding its portfolio to address unmet therapeutic needs. Beyond respiratory APIs, we are also prioritizing growth in CNS treatments and building on our expertise in complex molecule synthesis. This strategic focus allows us to provide an integrated solution that not only meets current market demands but also anticipates future pharmaceutical trends. HIGHLIGHTS// comprehensive portfolio of inhalation therapies/ over 20 years of experience in micronization and particle engineering/ specialize in bronchodilators and other critical respiratory APIs/ prioritizing growth in CNS treatments In the field of micronization, what differentiates Inke’s approach from that of other manufacturers of respiratory APIs? What sets Inke apart in micronization is our advanced particle size reduction technology and our dedication to precision. Our facility is equipped with various milling techniques such as Cone, Jet, and Pin mills, allowing us to reduce particle size while stabilizing the amorphous content to ensure consistent quality. Our in-depth understanding of respiratory APIs, combined with our ability to tailor solutions for each customer, results in APIs with improved solubility, stability, and bioavailability, which are critical for the efficacy of inhalation products. This, along with our exceptional quality standards and a flawless audit track record, has positioned us as a key partner for major players in the inhalation market. HIGHLIGHTS// advanced particle size reduction technology/ technological innovations/ tailor solutions/ improved solubility, stability, and bioavailability Developing complex APIs can be challenging. How does Inke ensure a smooth and successful partnership throughout the development and manufacturing process, including customization, ensuring regulatory compliance and timely delivery? At Inke, we are dedicated to fostering strong partnerships with our clients through a collaborative approach that prioritizes open communication and mutual understanding. Our commitment to quality and personalized service sets us apart in the pharmaceutical landscape. Our team takes the time to engage in comprehensive discussions to customize our solutions, ensuring alignment with client specifications across all batches and grades. This commitment to flexibility allows us to respond effectively to evolving requirements, solidifying Inke’s reputation as a reliable partner. We understand that navigating regulatory landscapes can be challenging. That's why our team is equipped to manage all aspects of the regulatory process with meticulous attention to detail. From the submission of Drug Master Files (DMFs) and Certificates of Suitability to crafting precise responses to potential Deficiency Letters, we ensure compliance at every step. Moreover, we offer extensive support in patent and intellectual property matters, providing technical assistance and guidance tailored to the specific requirements of each region. Our unwavering dedication to quality, coupled with our agile response capabilities, enables us to deliver exceptional results while maintaining transparency and trust. At Inke, we are committed to building lasting relationships that drive success for both our clients and our organization. HIGHLIGHTS// ensuring alignment with client specifications/ manage all aspects of the regulatory process/ support in patent and intellectual property matters Given Inke’s global presence, what are the key markets for growth and how does Inke plan to expand its market reach and strengthen its position in these regions? Inke is strategically focused on expanding its footprint in the European and US markets, where we continue to prioritize our efforts. The US market remains pivotal for us, especially considering our successful FDA inspections and ongoing regulatory compliance efforts that solidify our reputation. Japan is another significant market where we have established a robust presence, reflecting our commitment to high-quality manufacturing and innovation. Looking ahead, China represents a key growth opportunity for Inke. With 12 active DMFs registered, we are well-positioned to tap into this burgeoning market. Our strategy involves leveraging our existing capabilities to navigate regulatory landscapes and fostering strong partnerships within the region, thereby enhancing our market reach and influence in the pharmaceutical sector. HIGHLIGHTS// expanding footprint in the European and US markets/ China represents a key growth opportunity for Inke With Inke expanding into contract manufacturing organization (CMO) services, how does this new offering align with Inke’s broader strategic goals, and what advantages does it provide to pharmaceutical partners? At Inke, the introduction of CMO services is a natural extension of our core expertise in the development and manufacturing of high-quality generic APIs. Our expansion into CMO is part of a strategic move to diversify our service portfolio, allowing us to offer end-to-end solutions for our clients. The CMO service integrates seamlessly with our expertise in API manufacturing, particularly in micronization, which has been a key differentiator for Inke for over two decades. With our advanced particle engineering capabilities, we can offer tailored solutions that meet specific technical and regulatory requirements. Whether it is small-batch production or scaling up to commercial quantities, we offer the flexibility to accommodate a wide range of customer needs. This adaptability, paired with our deep expertise in micronization, allows us to support evolving project needs, maintaining the highest standards of consistency, quality, and performance that define Inke’s footprint. HIGHLIGHTS// CMO is part of a strategic move to diversify our service portfolio/ deep expertise in micronization What is Inke’s commitment to sustainability and corporate social responsibility and how is it integrating sustainable practices into its operations and product development? At Inke, we recognize that integrating environmental, social, and governance (ESG) principles into our operations is not just a responsibility but a pathway to long-term success. Our ESG vision is centered around aligning business growth with sustainable practices that positively impact our communities and the environment. We are dedicated to environmental responsibility, actively implementing initiatives such as efficient wastewater treatment and water reuse systems to minimize our ecological footprint. Our recent investments in energy efficiency include the installation of a 135 kWp solar panel system, which underscores our commitment to reducing emissions and resource consumption across our manufacturing and research facilities. Inke is also committed to fostering a diverse and inclusive workforce. With a notable increase in our team members, particularly in operations and quality assurance, we prioritize career development and the well-being of our employees. By adhering to high regulatory standards, we ensure our products meet stringent global requirements, enhancing our transparency and compliance. Through these initiatives, Inke aims to cultivate sustainable practices that not only support our business objectives but also contribute positively to the pharmaceutical industry and society at large. HIGHLIGHTS// integrating ESG principles/ efficient wastewater treatment and water reuse systems/ installation of a 135 kWp solar panel system/ diverse and inclusive workforce

    Impressions: 430

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

    #SpeakPharma With Inke
    28 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2489

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

    #PharmaFlow by PHARMACOMPASS
    24 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Glenmark arm recalls products in US for manufacturing issues
    Glenmark arm recalls products in US for manufacturing issues

    13 Oct 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-arm-recalls-products-in-us-for-manufacturing-issues/articleshow/114184714.cms

    ECONOMICTIMES
    13 Oct 2024
    Share Share
    Enforcement Report - Week of October 9, 2024
    Enforcement Report - Week of October 9, 2024

    09 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-9-2024-25441.pdf

    FDA
    09 Oct 2024
    Share Share
    Enforcement Report - Week of October 2, 2024
    Enforcement Report - Week of October 2, 2024

    02 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-2-2024-89540.pdf

    FDA
    02 Oct 2024
    Share Share
    Ichnos-Glenmark Antibody Outperforms J&J's Tecvayli In Mice Study
    Ichnos-Glenmark Antibody Outperforms J&J's Tecvayli In Mice Study

    17 Sep 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/trispecific-antibody-ichnos-glenmark-innovation-beats-janssens-tecvayli-treating-multiple

    FIERCE BIOTECH
    17 Sep 2024
    Share Share
    Glenmark to pay USD 25 mn as part of settlement with US authorities
    Glenmark to pay USD 25 mn as part of settlement with US authorities

    05 Sep 2024

    // ECONOMICTIMES

    https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/glenmark-to-pay-usd-25-mn-as-part-of-settlement-with-us-authorities/113086994?utm_source=top_news&utm_medium=sectionListing

    ECONOMICTIMES
    05 Sep 2024
    Share Share
    Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
    Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution

    19 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/glenmark-therapeutics-inc-usa-launches-olopatadine-hydrochloride-ophthalmic-solution-usp-0-1-otc-302225295.html

    PR NEWSWIRE
    19 Aug 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Adapalene

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Adapalene

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-08

    Pay. Date : 2012-11-26

    DMF Number : 18756

    Submission : 2005-09-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-207 - Rev 01

    Issue Date : 2022-12-06

    Type : Chemical

    Substance Number : 2445

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10072

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2014-03-11

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-801

    Start Marketing Date : 2005-09-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Esomeprazole Magnesium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Esomeprazole Magnesium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-06-05

    Pay. Date : 2013-03-08

    DMF Number : 20222

    Submission : 2007-01-31

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-258 - Rev 02

    Issue Date : 2023-02-09

    Type : Chemical

    Substance Number : 2787

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10113

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2021-07-16

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-827

    Start Marketing Date : 2007-01-31

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : SG Biochem Co., Ltd.

    Registration Date : 2023-12-27

    Registration Number : 20230925-127-H-416-46(1)

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109, GIDC Industrial Estate Ankleshwar - 393 002, Dist. Bharuch, Gujarat State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Rizatriptan Benzoate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Rizatriptan Benzoate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22676

    Submission : 2009-03-31

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-108 - Rev 02

    Issue Date : 2022-12-05

    Type : Chemical

    Substance Number : 2585

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 228MF10064

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2016-02-24

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-835

    Start Marketing Date : 2009-03-31

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Ropinirole Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Ropinirole Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2022-11-16

    Pay. Date : 2022-11-14

    DMF Number : 20593

    Submission : 2007-06-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2017-242 - Rev 01

    Issue Date : 2022-12-13

    Type : Chemical

    Substance Number : 2604

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10031

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2015-01-23

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-853

    Start Marketing Date : 2007-06-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Solifenacin Succinate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Solifenacin Succinate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-10-17

    Pay. Date : 2012-12-07

    DMF Number : 22418

    Submission : 2009-01-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-249 - Rev 02

    Issue Date : 2024-04-04

    Type : Chemical

    Substance Number : 2779

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10112

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2024-08-22

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-858

    Start Marketing Date : 2009-01-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Astellas Pharma Korea Co., Ltd.

    Registration Date : 2024-09-04

    Registration Number : No. 4692-7-ND(3)

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109-C, GIDC Industrial Estate, Ankleshwar - 393 002, Dist. Bharuch, Gurajat State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Tadalafil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Tadalafil

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22530

    Submission : 2009-02-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-040 - Rev 00

    Issue Date : 2022-06-29

    Type : Chemical

    Substance Number : 2606

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 231MF10055

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2019-02-25

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-843

    Start Marketing Date : 2009-02-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sangjin Corporation

    Registration Date : 2014-02-07

    Registration Number : 20140207-203-I-371-06

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109, GIDC, Industrial Estate, Ankleshwar. City : Ankleshwar - 393 002, Dist : Bharuch, Gujarat State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Voriconazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Voriconazole

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-01-14

    Pay. Date : 2013-12-13

    DMF Number : 24717

    Submission : 2011-03-31

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-102 - Rev 02

    Issue Date : 2022-12-05

    Type : Chemical

    Substance Number : 2576

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10092

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2013-05-08

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-876

    Start Marketing Date : 2011-08-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Aging Life Science Co., Ltd.

    Registration Date : 2020-07-21

    Registration Number : 20200721-209-J-382

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109, GIDC Industrial Estate, Ankleshwar City : Ankleshwar - 393 002, Dist : Bharuch, Gujarat State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Zolpidem Tartrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Zolpidem Tartrate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-31

    Pay. Date : 2013-01-04

    DMF Number : 18164

    Submission : 2005-03-14

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-102 - Rev 04

    Issue Date : 2022-12-05

    Type : Chemical

    Substance Number : 1280

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10236

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2015-09-24

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-810

    Start Marketing Date : 2005-03-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Telmisartan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Telmisartan

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-07-25

    Pay. Date : 2014-05-23

    DMF Number : 27804

    Submission : 2014-05-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-028 - Rev 06

    Issue Date : 2022-12-06

    Type : Chemical

    Substance Number : 2154

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10093

    Registrant's Address : Glenmark House, HDO Corporate Building, Wing A, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai

    Initial Date of Registration : 2013-05-08

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-05-27

    Valid Till : 2023-11-23

    Written Confirmation Number : WC-0310A3-4

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-895

    Start Marketing Date : 2014-05-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : M-Peak Korea Co., Ltd.

    Registration Date : 2018-05-09

    Registration Number : 20180509-209-J-30

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109-GIDC Industrial Estate ANKLESHWAR-393002 Dist. Bharuch, Gujarat, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Telmisartan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Telmisartan

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20575

    Submission : 2007-05-25

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2024-184 - Rev 00

    Issue Date : 2024-08-29

    Type : Chemical

    Substance Number : 2154

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 228MF10025

    Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Maharashtra, India

    Initial Date of Registration : 2016-02-02

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-07

    Valid Till : 2025-06-25

    Written Confirmation Number : WC-0057n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 66039-895

    Start Marketing Date : 2014-05-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : M-Peak Korea Co., Ltd.

    Registration Date : 2018-05-09

    Registration Number : 20180509-209-J-30

    Manufacturer Name : Glenmark Life Sciences Limited

    Manufacturer Address : Plot No. 3109-GIDC Industrial Estate ANKLESHWAR-393002 Dist. Bharuch, Gujarat, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-06-29

    Glenmark Pharmaceuticals

    City : Mahwah

    State : NJ

    Country/Area : US

    Zip : 07430-2009

    District : NWJ

    Center : CDER

    Project Area : Postmarket Surv. and Epidemiolog...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-06-29

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2011-09-09

    Glenmark Pharmaceuticals

    City : Mahwah

    State : NJ

    Country/Area : US

    Zip : 07430-2009

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2011-09-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-11-20

    Glenmark Pharmaceuticals

    City : Colvale Bardez, Goa

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-11-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-12

    Glenmark Pharmaceuticals

    City : Colvale Bardez, Goa

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-15

    Glenmark Pharmaceuticals

    City : Ankleshwar

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-10-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-08-24

    Glenmark Pharmaceuticals

    City : Solan

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2012-08-24

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-07-19

    Glenmark Pharmaceuticals

    City : Colvale Bardez, Goa

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-07-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-05-27

    Glenmark Pharmaceuticals

    City : Pilar

    State :

    Country/Area : AR

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-05-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-30

    Glenmark Pharmaceuticals

    City : Colvale Bardez, Goa

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    SupplySide West 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-04-17

    Glenmark Pharmaceuticals

    City : Dahej

    State :

    Country/Area : IN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-04-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : 056/2010/RO

    EudraGMDP Key : 10854

    Country : United Kingdom

    Issue Date :

    Post Code : 393 002

    NCA Ref : 1.0854131108...

    City : Ankleshwar

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : UK GMP 1735...

    EudraGMDP Key : 11919

    Country : United Kingdom

    Issue Date :

    Post Code : IN 403513

    NCA Ref : 120518-GLENM...

    City : BARDEZ

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : HMP/PT/16/2...

    EudraGMDP Key : 11988

    Country : United Kingdom

    Issue Date :

    Post Code : 393002

    NCA Ref : A091 5446 84...

    City : ANKLESHWAR

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : sukls12455/...

    EudraGMDP Key : 11919

    Country : United Kingdom

    Issue Date :

    Post Code : IN 403513

    NCA Ref : 120518-GLENM...

    City : BARDEZ

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : UK GMP 1735...

    EudraGMDP Key : 12233

    Country : United Kingdom

    Issue Date :

    Post Code : IN-454 774

    NCA Ref : 5879877-GLEN...

    City : PITHAMPUR, DHAR DISTRIC...

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : UK GMP 1735...

    EudraGMDP Key : 9983

    Country : United Kingdom

    Issue Date :

    Post Code : IN-174101

    NCA Ref : 382961-GLENM...

    City : SOLAN DISTRICT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : UK GMP 4173...

    EudraGMDP Key : 14988

    Country : United Kingdom

    Issue Date :

    Post Code : AR-B1629MX

    NCA Ref : 7009036-GLEN...

    City : BUENOS AIRES

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    GMP Certified

    EU
    SupplySide West 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    SupplySide West 2024
    Not Confirmed

    Glenmark Pharmaceuticals

    Type : GMP Certificates

    Number : 4573/12.01....

    EudraGMDP Key : 10854

    Country : India

    Issue Date : 2014-07-02

    Post Code : 393 002

    NCA Ref : 1.09E+17

    City : Ankleshwar

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    WHO-GMP

    read-more
    read-more

    01

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : M/s Glenmark Generics 'Ltd., Plot no. S-7, Colvale, Bardez-Goa 403 513

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    03

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    04

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : Glenmark Pharmaceuticals Ltd. Village Kishanpura, Baddi-Nalagarh Road, Tehsil Nalagarh, Distt. Solan (H.P.)

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : Glenmark Generics Limited Plot No. 2, Phase-II, Indore SEZ, Pithampur, District-Dhar

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : GLENMARK PHARMACEUTICALS LIMITED PLOT NO. - B -25, M.I.D.C, SHENDRA AURANGABAD 431210

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : GLENMARK PHARMACEUTICALS LIMITED PLOT NO. E-37, 39, D-ROAD, MIDC, SATPUR, NASHIK 422007

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    WHO GMP Certified

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    WHO GMP Certified

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Glenmark Pharmaceuticals

    Name and address of WHO GMP certified Manufacturer : M/s Glenmark Pharmaceuticals Ltd., Ranipool, East Sikkim- 737135

    Country : India

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    GDUFA

    read-more
    read-more

    01

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Generics S.A.

    Business Address : Calle 9 Ingeniero Meyer Oks ...

    FEI Number : 3009805225

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Pharmaceuticals Inc.,...

    Business Address : 4147 Goldmine Rd Monroe NC 2...

    FEI Number : 3011585599

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Plot No. 2, Phase-2, Pharma ...

    FEI Number : 3008565058

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Plot no Z-103-I SEZ Phase II...

    FEI Number : 3007514214

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Plot No. 3109, GIDC Industri...

    FEI Number : 3004006229

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Plot No B-25, MIDC, Shendra ...

    FEI Number : 3009915929

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Plot No S-7, Colvale Industr...

    FEI Number : 3004672766

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    GDUFA fees paid

    USA
    SupplySide West 2024
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2019

    Glenmark Pharmaceuticals

    API Manufacturer :

    FDF Manufacturer : FDF MANUFACTURE

    Facility Name : Glenmark Pharmaceuticals Limit...

    Business Address : Village Kishanpura Baddi Nal...

    FEI Number : 3005757050

    Country : India

    Paid in : 2019

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Glenmark Generics Europe Ltd and get a quotation

    Glenmark Generics Europe Ltd is a supplier offers 119 products (APIs, Excipients or Intermediates).

    Find a price of Alfuzosin HCl bulk offered by Glenmark Generics Europe Ltd

    Find a price of Fluconazole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Palonosetron bulk offered by Glenmark Generics Europe Ltd

    Find a price of Simvastatin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Tadalafil bulk offered by Glenmark Generics Europe Ltd

    Find a price of Telmisartan bulk offered by Glenmark Generics Europe Ltd

    Find a price of MFG SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR SATPUR NASIK INDIA SITE bulk offered by Glenmark Generics Europe Ltd

    Find a price of Adapalene bulk offered by Glenmark Generics Europe Ltd

    Find a price of Alogliptin Benzoate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Amiodarone Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Apixaban bulk offered by Glenmark Generics Europe Ltd

    Find a price of Apremilast bulk offered by Glenmark Generics Europe Ltd

    Find a price of Aprepitant bulk offered by Glenmark Generics Europe Ltd

    Find a price of Arformoterol Tartrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Atomoxetin Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Atovaquone bulk offered by Glenmark Generics Europe Ltd

    Find a price of Azelaic Acid bulk offered by Glenmark Generics Europe Ltd

    Find a price of Azelnidipine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Azilsartan bulk offered by Glenmark Generics Europe Ltd

    Find a price of Bilastine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Bosentan Hydrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Brivaracetam bulk offered by Glenmark Generics Europe Ltd

    Find a price of Bupropion Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Butenafine Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Canagliflozin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Cilazapril bulk offered by Glenmark Generics Europe Ltd

    Find a price of Cilostazol bulk offered by Glenmark Generics Europe Ltd

    Find a price of Colesevelam Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Colistimethate Sodium bulk offered by Glenmark Generics Europe Ltd

    Find a price of Dabigatran Etexilate Mesylate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Dapagliflozin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Deferasirox bulk offered by Glenmark Generics Europe Ltd

    Find a price of Deoxycholic Acid bulk offered by Glenmark Generics Europe Ltd

    Find a price of Desloratadine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Dimethyl Fumarate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Dipyridamole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Diroximel fumarate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Dronedarone Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Edoxaban Tosylate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Efinaconazole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Elagolix Sodium bulk offered by Glenmark Generics Europe Ltd

    Find a price of Empagliflozin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Eslicarbazepine Acetate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Esomeprazole Magnesium bulk offered by Glenmark Generics Europe Ltd

    Find a price of Esomeprazole Sodium bulk offered by Glenmark Generics Europe Ltd

    Find a price of Eszopiclone bulk offered by Glenmark Generics Europe Ltd

    Find a price of Etoricoxib bulk offered by Glenmark Generics Europe Ltd

    Find a price of Ezetimibe bulk offered by Glenmark Generics Europe Ltd

    Find a price of Favipiravir bulk offered by Glenmark Generics Europe Ltd

    Find a price of Fingolimod Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Fosaprepitant bulk offered by Glenmark Generics Europe Ltd

    Find a price of Frovatriptan bulk offered by Glenmark Generics Europe Ltd

    Find a price of Gabapentin Enacarbil bulk offered by Glenmark Generics Europe Ltd

    Find a price of Garenoxacin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Glimepiride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Hydralazine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Imiquimod bulk offered by Glenmark Generics Europe Ltd

    Find a price of Iron Sucrose bulk offered by Glenmark Generics Europe Ltd

    Find a price of Ivacaftor bulk offered by Glenmark Generics Europe Ltd

    Find a price of Labetalol Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lacosamide bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lasmiditan bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lercanidipine HCl bulk offered by Glenmark Generics Europe Ltd

    Find a price of Levocetirizine Dihydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lifitegrast bulk offered by Glenmark Generics Europe Ltd

    Find a price of Linagliptin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lithium Carbonate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lomitapide bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lornoxicam bulk offered by Glenmark Generics Europe Ltd

    Find a price of Luliconazole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Lurasidone Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Milnacipran HCl bulk offered by Glenmark Generics Europe Ltd

    Find a price of Mirabegron bulk offered by Glenmark Generics Europe Ltd

    Find a price of Moexipril bulk offered by Glenmark Generics Europe Ltd

    Find a price of Nebivolol bulk offered by Glenmark Generics Europe Ltd

    Find a price of Nintedanib Esylate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Olmesartan Medoxomil bulk offered by Glenmark Generics Europe Ltd

    Find a price of Olopatadine Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Omeprazole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Oxcarbazepine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Patiromer bulk offered by Glenmark Generics Europe Ltd

    Find a price of Perindopril Arginine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Perindopril Erbumine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Pirfenidone bulk offered by Glenmark Generics Europe Ltd

    Find a price of Prasugrel bulk offered by Glenmark Generics Europe Ltd

    Find a price of Proguanil bulk offered by Glenmark Generics Europe Ltd

    Find a price of Ranolazine bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rasagiline Mesylate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rasagiline Tartrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Riluzole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rivaroxaban bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rizatriptan Benzoate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Roflumilast bulk offered by Glenmark Generics Europe Ltd

    Find a price of Ropinirole Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rosuvastatin Calcium bulk offered by Glenmark Generics Europe Ltd

    Find a price of Rufinamide bulk offered by Glenmark Generics Europe Ltd

    Find a price of Saxagliptin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Sertaconazole Nitrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Solifenacin Succinate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Solriamfetol Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Sucralfate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Tafamidis bulk offered by Glenmark Generics Europe Ltd

    Find a price of Tavaborole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Teneligliptin Hydrobromide bulk offered by Glenmark Generics Europe Ltd

    Find a price of Terbinafine Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Teriflunomide bulk offered by Glenmark Generics Europe Ltd

    Find a price of Ticagrelor bulk offered by Glenmark Generics Europe Ltd

    Find a price of Tofacitinib Citrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Topiramate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Trandolapril bulk offered by Glenmark Generics Europe Ltd

    Find a price of Trospium Chloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Umifenovir bulk offered by Glenmark Generics Europe Ltd

    Find a price of Verapamil bulk offered by Glenmark Generics Europe Ltd

    Find a price of Vilazodone Hydrochloride bulk offered by Glenmark Generics Europe Ltd

    Find a price of Vildagliptin bulk offered by Glenmark Generics Europe Ltd

    Find a price of Voriconazole bulk offered by Glenmark Generics Europe Ltd

    Find a price of Zolmitriptan bulk offered by Glenmark Generics Europe Ltd

    Find a price of Zolpidem Tartrate bulk offered by Glenmark Generics Europe Ltd

    Find a price of Zonisamide bulk offered by Glenmark Generics Europe Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search